COMBINATION OF MITOXANTRONE AND ETOPOSIDE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA - AN ACTIVE AND WELL-TOLERATED REGIMEN

被引：124

作者：

HO, AD

LIPP, T

EHNINGER, G

ILLIGER, HJ

MEYER, P

FREUND, M

HUNSTEIN, W

机构：

[1] UNIV TUBINGEN, D-7400 TUBINGEN 1, GERMANY

[2] UNIV WURZBURG, D-8700 WURZBURG, GERMANY

[3] UNIV HANOVER, D-3000 Hannover, GERMANY

[4] MUNICIPAL HOSP, Munich, GERMANY

[5] MUNICIPAL HOSP, OLDENBURG, GERMANY

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 02期

关键词：

D O I：

10.1200/JCO.1988.6.2.213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：213 / 217

页数：5

共 47 条

[1]

ARLIN ZA, 1985, INVEST NEW DRUG, V3, P213

[2]

ARLIN ZA, 1986, 5TH NCI EORTC S NEW

[3] A PHASE-II TRIAL OF VP-16-213 IN ADULTS WITH REFRACTORY ACUTE MYELOID-LEUKEMIA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY [J].

BENNETT, JM ;

LYMANN, GH ;

CASSILETH, PA ;

GLICK, JH ;

OKEN, MM .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (05) :471-473

[4] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&

[5] MULTICENTER STUDY ON INTENSIFIED REMISSION INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA [J].

BUCHNER, T ;

URBANITZ, D ;

EMMERICH, B ;

FISCHER, JT ;

FULLE, HH ;

HEINECKE, A ;

HOSSFELD, DK ;

KOEPPEN, KM ;

LABEDZKI, L ;

LOFFLER, H ;

NOWROUSIAN, MR ;

PFREUNDSCHUH, M ;

PRALLE, H ;

RUHL, H ;

WENDT, FC .

LEUKEMIA RESEARCH, 1982, 6 (06) :827-831

[6]

CAPIZZI RL, 1984, BLOOD, V63, P694

[7]

CHAMPLIN R, 1984, LANCET, V1, P894

[8]

EARLY AP, 1982, CANCER RES, V42, P1587

[9]

ESTEY EH, 1983, CANCER TREAT REP, V67, P389

[10]

FREIREICH EJ, 1978, CANCER-AM CANCER SOC, V42, P874, DOI 10.1002/1097-0142(197808)42:2+<874::AID-CNCR2820420709>3.0.CO

← 1 2 3 4 5 →